Mutational screen reveals a novel JAK mutation, L611S, in a child with acute lymphoblastic leukemia [14]

Leukemia

Volumn 20, Issue 2, 2006, Pages 381-383

  Kratz, C P ^a   Boll S ^a   Kontny, U ^a   Schrappe, M ^b   Niemeyer, C M ^a   Stanulla, M ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; JANUS KINASE 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; BONE MARROW EXAMINATION; CHILD; CLINICAL FEATURE; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; GENETIC SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; LEUKEMOGENESIS; MOLECULAR DYNAMICS; MUTANT; PRIORITY JOURNAL; WILD TYPE;

EID: 31444432749     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404060     Document Type: Letter

References (8)

1. Reiter A, Walz C, Watmore A, Schoch C, Blau I, Schlegelberger B et al. The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2. Cancer Res 2005; 65: 2662-2667.
2. Shannon K, Van Etten RA. JAKing up hematopoietic proliferation. Cancer Cell 2005; 7: 291-293.
3. Jelinek J, Oki Y, Gharibyan V, Bueso-Ramos C, Prchal JT, Verstovsek S et al. JAK2 mutation 1849G >T is rare in acute leukemias but can be found in CMML, Philadelphia-chromosome negative CML and megakaryocytic leukemia. Blood 2005; 106: 3370-3373.
4. Levine RL, Loriaux M, Huntly BJ, Loh M, Beran M, Stoffregen E et al. The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia. Blood 2005; 106: 3377-3379.
5. Steensma DP, Dewald GW, Lasho TL, Powell HL, McClure RF, Levine RL et al. The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both 'atypical' myeloproliferative disorders and myelodysplastic syndromes. Blood 2005; 106: 1207-1209.
6. Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005; 106: 2162-2168.
7. Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M et al. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 1997; 278: 1309-1312.
8. Sulong S, Case M, Minto L, Wilkins B, Hall A, Irving J. The V617F mutation in Jak2 is not found in childhood acute lymphoblastic leukaemia. Br J Haematol 2005; 130: 964-965.